Safety and Immune Response to a Clade C DNA HIV Vaccine
Clinical trial NCT02997969 · COMPLETED
Trial details
- NCT number
- NCT02997969
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-21
- Primary completion
- 2018-07-11
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.